|
?:authorAffiliation
|
-
[\'Swedish Center for Research and Innovation, Swedish Medical Center, Seattle, Washington, USA jason.goldman@swedish.org.\', \'Providence St. Joseph Health, Renton, Washington, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.\', \'The University of Queensland Faculty of Medicine, Herston, Queensland, Australia.\', \'Metro North Hospital and Health Service, Royal Brisbane and Woman\'s Hospital Health Service District, Herston, Queensland, Australia.\', \'Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.\', \'Department. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Karolinska Comprehensive Cancer Center, Stockholm, Sweden.\', \'Division of Hematology, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}